Overview
Thank you to all the delegates who attended the FT Global Pharmaceutical & Biotechnology Conference 2011, Europe's pre-eminent industry event attended by over 300 delegates over 2 insightful days of discussion between leading industry executives, government decision makers, investors, analysts and other specialist providers.
| |
|
| CONFERENCE CHAIRED BY: |
|||||
|
CONFIRMED SPEAKERS INCLUDED:
![]()
|
Issues addressed included:
- Incentivising and rewarding innovation: what innovation is worth paying for?
- Emerging markets: transforming the life science business model for the needs of emerging markets
- Pharma and consumer businesses -healthy convergence or awkward partners?
- R&D: new financing and business models for innovation
- Strategy forum: how is the nature of competition in the life sciences industry changing? What will the pharma company of the future look like?




